Clinical Outcome of Delayed or Standard Prograf Together With Induction Therapy Followed by Conversion to Advagraf in DCD Kidney Transplant Recipients: A Randomized, Open-label, Multicenter Clinical Trial
Phase of Trial: Phase IV
Latest Information Update: 24 Jan 2019
At a glance
- Drugs Tacrolimus (Primary) ; Corticosteroids; Mycophenolic acid
- Indications Renal transplant rejection
- Focus Therapeutic Use
- Sponsors Astellas Pharma China
- 31 Oct 2018 Status changed from not yet recruiting to recruiting.
- 09 Oct 2018 Planned initiation date changed from 1 Sep 2018 to 1 Oct 2018.
- 30 Aug 2018 New trial record